• Home
    • HMO/Medical Excess
    • Provider Excess
    • Employer Stop Loss
    • Managed Care Services
    • Capital Management Solutions
    • Letter from the President
    • Underwriting Methodology
    • Core Values
    • Leadership Team
    • Partners and Producers
    • Affiliations
    • Industry News
    • Summit Perspectives
    • Events
  • Contact
    • Forms
    • Articles
    • Brochures
Menu

Summit Re

6920 Pointe Inverness Way, Suite 140
Fort Wayne, IN, 46804
2604073977
 
Extranet - login

Summit Re

  • Home
  • Markets
    • HMO/Medical Excess
    • Provider Excess
    • Employer Stop Loss
    • Managed Care Services
    • Capital Management Solutions
  • Our Company
    • Letter from the President
    • Underwriting Methodology
    • Core Values
    • Leadership Team
    • Partners and Producers
    • Affiliations
  • News
    • Industry News
    • Summit Perspectives
    • Events
  • Contact
  • Library
    • Forms
    • Articles
    • Brochures

FDA Approval of Aduhelm (Aducanumab) for Alzheimer's Disease →

July 12, 2021 summitre
← Mary Sullivan Joins Summit Re's Sales TeamSummit Re Makes Key Addition to Sales Team →
 

Summit Reinsurance Services, Inc. • 6920 Pointe Inverness Way, Suite 140, Fort Wayne, IN 46804 • 260.469.3000

Copyright © 2017-2024 Summit Reinsurance Services, Inc. All rights reserved.

Terms of Use | Website Privacy Policy | HIPAA Privacy Practices | Non-Discrimination Statement and Foreign Language Access

In NY, Summit Re operates under the name Summit Reinsurance Intermediary Brokerage Services.

In CA, Summit Re operates under the name Summit of Indiana Insurance Services.